Medicinal Products

Reblozyl

The medicinal product has been authorised by the European Commission (EC) via centralised procedure in all EU Member States, based on the European Medicines Agency (EMA) experts' opinion.

Name Reblozyl
Active Substance luspatercept
Prescription na recept
Type of prescription ograničeni recept
Distribution u ljekarni
ATC Code B03XA06
Summary of product characteristics (SmPC), labelling and package leaflet (PL) download
Link to the European Medicines Agency's (EMA) product information download
Link to the European Commission's (EC) decisions download
Back